Homocysteine

Physiological Role

Homocysteine is a sulfur-containing amino acid produced at the crossroads of the methionine cycle. This cycle generates S-adenosylmethionine (SAM), the body's universal methyl group donor. SAM is involved in over 200 enzymatic reactions, from gene regulation to neurotransmitter synthesis.

Two metabolic pathways eliminate homocysteine. Remethylation converts it back to methionine using folate (vitamin B9) and vitamin B12. Transsulfuration transforms it into cysteine via vitamin B6. Both pathways work in parallel to keep homocysteine levels low.

When B vitamin intake is insufficient or a genetic polymorphism slows one of these pathways, homocysteine accumulates in plasma. Its level therefore simultaneously reflects the status of three essential cofactors and the proper functioning of the cellular methylation machinery.

Reference Ranges

Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.

Biological Significance

Homocysteine levels in the optimal zone indicate the methylation cycle is functioning efficiently. Vitamin cofactors (B9, B12, B6) are present in sufficient quantities to ensure proper recycling of this amino acid. This profile is associated with better vascular integrity and lower cognitive risk.

Elevated values signal a slowdown in the methylation cycle. Several scenarios may explain this. Insufficient folate or vitamin B12 intake is the most common cause. An MTHFR gene polymorphism may also slow folate conversion to its active form. Cross-reading with vitamin B9 and B12 levels helps identify the source of imbalance.

This marker varies from one draw to the next in the same person, without anything having changed: a difference of about 25 to 30% between two assessments is needed before it can be considered real. A single value therefore reads as a point, never as a trend.

Other elements shift this level independently of the methylation cycle: the delay between the blood draw and sample preparation at the laboratory, age, kidney function, or other components of a formula. A decrease observed from one assessment to the next does not, on its own, prove that the cofactors have done their work.

Influencing Factors

Diet. Folate comes primarily from leafy green vegetables, legumes and citrus fruits. A diet low in these foods reduces vitamin B9 availability, a direct cofactor in homocysteine recycling. Vitamin B12 is supplied by animal proteins. Unsupplemented vegan diets carry an increased risk of elevated levels.

Genetics. The MTHFR C677T polymorphism is present in homozygous form in about 12% of northern Europeans and up to 24% of southern Europeans. It reduces the activity of the enzyme that converts folate to its active form. Carriers of this variant have increased methylfolate requirements to maintain favorable homocysteine levels.

Age and sex. Homocysteine naturally increases with age, particularly after menopause in women. Men generally have slightly higher levels than women of childbearing age.

Kidney function. The kidneys participate in homocysteine clearance. Impaired kidney function can contribute to its accumulation, independently of vitamin status.

Lifestyle. Regular tobacco use and sedentary behavior are associated with higher levels. Regular physical activity helps maintain a more favorable metabolic profile.

Supplementation. Vitamin B9, vitamin B12 and vitamin B6 (P5P) are the three cofactors of the methylation cycle. Adequate intake of these vitamins contributes to normal homocysteine metabolism.

Medications. Certain medications, including methotrexate and enzyme-inducing antiepileptics, interfere with B vitamin metabolism and contribute to elevated homocysteine.

In the Singular Formula

Homocysteine holds a central role in Singular formula personalization. This biomarker triggers a set of adjustment rules that modulate the dosages of three key methylation cycle cofactors.

Two conditions raise vitamin B6 (P5P) to its reinforced dosage. Homocysteine must be elevated, and PLP must not exceed the first third of its optimal zone. Vitamin B6 is involved in transsulfuration, the second pathway for homocysteine elimination. If vitamin B12 levels are simultaneously low, vitamin B12 dosage is also increased to support the remethylation pathway. Similarly, when vitamin B9 status is low it is that status which drives the higher vitamin B9 dosage: elevated homocysteine indicates that the remethylation pathway lacks cofactors, it does not set the level of the intake.

When homocysteine is elevated, vitamin B9 and vitamin B12 are optimal and alkaline phosphatase is outside its very high zone, the logic shifts. The formula then includes vitamin B9 and vitamin B12 at their maintenance dose, to support the cycle without excess. This graduated logic reflects the calibration principle that guides the formulation engine.

Homocysteine is also read alongside mean corpuscular volume. When both are elevated, vitamin B12 is not low and vitamin B9 is low, missing or in the lower part of its optimal zone, the formula combines a reinforced vitamin B9 dosage with a maintenance vitamin B12 dosage.

Scientific Studies

Frequently Asked Questions